Philips | PHIA - Cost Of Sales


Philips reported EUR2.14B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
ABB USD 5.29B 201M Mar/2026
Abbott USD 5.3B 380M Mar/2026
Aena EUR 239.42M 36.35M Mar/2026
Alcon AG USD 1.18B 26M Mar/2026
ASM International NV EUR 402.7M 52.1M Mar/2026
ASML Holding 4.12B 527.6M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Demant DKK 2.89B 188M Dec/2025
EDAP TMS EUR 7.91M 1.31M Sep/2025
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Geberit CHF 229.8M 22.8M Dec/2025
Getinge SEK 6.02B 1.7B Dec/2024
GN Store Nord DKK 1.16B 1.08B Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
HeidelbergCement EUR 4.47B 31.6M Dec/2025
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Koninklijke Philips EUR 3.27B 475.1M Dec/2025
Legrand EUR 1.26B 17.9M Mar/2026
Lonza CHF 2.28B 189M Jun/2025
Medtronic USD 3.8B 195M Mar/2026
Merck EUR 2.07B 219M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026
SAP EUR 2.58B 20M Mar/2026
Schneider Electric EUR 12.35B 1.29B Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025